CHARLOTTETOWN, Prince Edward Island & VANCOUVER, British Columbia--(BUSINESS WIRE)--BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service ...
The manufacture and release of mRNA therapeutics and vaccines is a complex and challenging process requiring a high degree of expertise, capabilities, and experience. The development and manufacturing ...
Boston Consulting Group, Mountain View, CA, USA. Lipid nanoparticles (LNPs) have recently risen to prominence as the technology platform that enables the delivery of mRNA, the key component of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results